Novocure Receives MHLW Approval for Second Generation OptuneĀ® in Japan

Go back to Novocure Receives MHLW Approval for Second Generation OptuneĀ® in Japan
(NASDAQ: NVCR) Delayed: 17.77 --0 (-0%)
Previous Close $17.77    52 Week High $28.95 
Open $17.77    52 Week Low $5.95 
Day High $17.77    P/E N/A 
Day Low $17.77    EPS $0.00 
Volume 1,035